Nautilus Biotechnology (NAUT) Non Operating Interest Expenses (2022 - 2026)

Nautilus Biotechnology has disclosed Non Operating Interest Expenses across 5 years of filings, most recently posting $15000.0 for Q1 2026.

• In Q1 2026, Non Operating Interest Expenses changed N/A year-over-year to $15000.0; the TTM figure through Mar 2026 stood at $47000.0 (down 44.05% YoY), while the FY2025 annual figure was $32000.0, down 61.9% from the prior year.
• Non Operating Interest Expenses came in at $15000.0 for Q1 2026 at Nautilus Biotechnology, up from $11000.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $56000.0 in Q4 2023 to a low of $3000.0 in Q1 2023.
• Average Non Operating Interest Expenses over 5 years is $19000.0, with a median of $15000.0 recorded in 2026.
• Year-over-year, Non Operating Interest Expenses soared 35.71% in 2024 and sank 75.56% in 2025.
• Over 5 years, Non Operating Interest Expenses stood at $5000.0 in 2022, then jumped by 1020.0% to $56000.0 in 2023, then slipped by 19.64% to $45000.0 in 2024, then slumped by 75.56% to $11000.0 in 2025, then jumped by 36.36% to $15000.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $15000.0 in Q1 2026, $11000.0 in Q4 2025, and $5000.0 in Q3 2025.